key: cord-1018566-v5pd3zqb
authors: Castineiras, Terezinha Marta Pereira Pinto; Nascimento, Érica Ramos dos Santos; Faffe, Débora Souza; Galliez, Rafael Mello; Mariani, Diana; Leitão, Isabela de Carvalho; de Melo, Mayla Gabryele Miranda; Ferreira, Orlando Costa; Tanuri, Amilcar
title: Performance of an alternative RT-PCR procedure using residual sample from the Panbio™ Ag COVID-19 test
date: 2021-10-12
journal: Braz J Infect Dis
DOI: 10.1016/j.bjid.2021.101630
sha: 3409f0ab0e7d98f5e688c58e75797e8e87a560a8
doc_id: 1018566
cord_uid: v5pd3zqb

INTRODUCTION: In the current standard of care (SoC) RT-PCR method for COVID-19, the patient's swab was extracted in viral transport media (VTM). For the Panbio™ COVID-19 Ag Rapid Test, the patient swab is flushed out in extraction buffer, of which a small fraction is used for testing, leaving more than half the sample unused. This study was designed to show that RT-PCR results from the residual sample of the Panbio™ COVID-19 Ag Rapid Test (called Novel RT-PCR) are not worse than the SoC RT-PCR result. METHODS: The study was performed using (1) dilution series of five patient samples, and (2) 413 patient samples comparing SOC versus Novel RT-PCR results. RESULTS: For the dilution series samples, all tested positive by both methods. The bias between Ct values of Novel RT-PCR and SoC RT-PCR did not exceed 3.00 Ct using primers N1 and N2. A total of 413 COVID symptomatic patients seeking COVID testing were tested, of which 89 patients tested positive and 324 tested negative with SoC RT-PCR. In 324 patients who tested negative with SoC RT-PCR, 323 tested negative with Novel RT-PCR, and one (1) tested positive. Out of 89 who tested positive with SoC RT-PCR, 80 tested positive with the Novel RT-PCR, and nine patients showed a negative test result. The Overall Percent Agreement for the 413 valid patient sample pairs was 97.5 [95% CI 97 to 98]. CONCLUSION: The study demonstrated that the performance of the Novel RT-PCR method is acceptable compared to the SoC RT-PCR method and can be a useful tool to perform RT-PCR without the need for new swab collections.

Performance of an alternative RT-PCR procedure using residual sample from the Panbio TM Ag COVID-19 test Q1 X XD 1 X XTerezinha Marta Pereira Pinto Castineiras D 2 X X b,1 , D 3 X X Erica Ramos dos Santos Nascimento D 4 X X a,1 , D 5 X XD ebora Souza Faffe D 6 X X c,1 , D 7 X XRafael Mello Galliez D 8 X X b , D 9 X XDiana Mariani D 1 0 X X a , D 1 1 X XIsabela de Carvalho Leitão D 1 2 X X c , D 1 3 X XMayla Gabryele Miranda de Melo D 1 4 X X 2 Virological testing plays a critical role in the global response 3 to the SARS-CoV-2 pandemic. Q2 X X 1−3 Early diagnosis allows infec-4 tious cases to be isolated in a timely manner curbing viral 5 transmission. In addition, early diagnosis and initiation of 6 appropriate supportive therapy can improve outcomes and 7 prevent mortality. 4−7 The majority of well-resourced coun-8 tries have implemented large scale nucleic acid tests (NATs) 9 for COVID-19 diagnosis. NATs have the benefit of high sensi-10 tivity and specificity for current or recent infection. However, 11 these tests are challenging to implement in large scale in 12 resource-poor settings due to cost, lack of good specimen 13 transport systems and lack of both laboratory infrastructure 14 and highly trained technicians. The turnaround time for NAT 15 results can also be an issue and it is common for results to be 16 reported 1-2 weeks after specimen collection. 8 series, we did not assume that these two samples must be 159 considered as outliers for example due to technical issues. The bias is the difference between perfect agreement (i.e. 176 identity line) and the effective agreement (fitted regression 177 line) of both methods. Bias is reported for the borders of the 178 covered Ct value range as well as for Ct 33.00 in Table 1 179 together with the corresponding upper one-sided 95% confi- Table 2 ). In summary, the study proved that the performance of the 240 Novel RT-PCR method is acceptable compared to the SoC RT- 

A visual inspection of this difference plot was per-198 formed to characterize the variability of differences and to 199 screen for potential outliers. The Bland-Altman plot did not 200 reveal any obvious patterns or drifts in the data

The Novel RT-PCR shows generated higher Ct values when 205 compared to the SoC RT-PCR. This fact means that the 206 amount of viral genetic material recovered Panbio TM COVID

Ag Rapid Test extraction buffer is lower when compared to 208 quantity isolated from standard swab in Virus Transportation

Taking into consideration the data from all 80 patient 210 samples, the mean difference was 2.58 and 2.99 Ct for the N1 211 and N2 target region, respectively

Ag Rapid Test for RT-PCR will facilitate 243 specimen collection for both tests (Ag RDT and RT-PCR) by 244 avoiding multiple collection in patients seeking COVID-19 245 diagnosis. In a logical way, the Novel RT-PCR explained here 246 can be used as a tie-breaker test when needed or for Ag

The UFRJ COVID-19 Working group is composed by: C assia

Della Pascoa França 3 , and Victor Akira Ota 4 . 1 Department of

UFRJ), Brazil; 2 Biological Science Institute

World Health Organisation

Response Progress Report -1 February to. WHO

Diagnostic Testing